Total Payments
$748.13
2024 Payments
$233.58
Companies
13
Transactions
39
Medicare Patients
315
Medicare Billing
$17,229
Payment Breakdown by Category
Food & Beverage$748.13 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $748.13 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $217.93 | 10 | $0 (2024) |
| Novo Nordisk Inc | $138.94 | 7 | $0 (2024) |
| Merck Sharp & Dohme LLC | $60.69 | 3 | $0 (2024) |
| Amgen Inc. | $54.52 | 3 | $0 (2024) |
| Lilly USA, LLC | $45.28 | 3 | $0 (2022) |
| Exact Sciences Corporation | $40.37 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $40.26 | 3 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.71 | 2 | $0 (2022) |
| PFIZER INC. | $33.12 | 2 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $22.78 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $233.58 | 12 | Novo Nordisk Inc ($59.09) |
| 2023 | $239.77 | 12 | ABBVIE INC. ($102.66) |
| 2022 | $230.20 | 12 | ABBVIE INC. ($86.59) |
| 2021 | $30.88 | 2 | Lilly USA, LLC ($17.75) |
| 2020 | $13.70 | 1 | Merck Sharp & Dohme Corporation ($13.70) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $16.69 | General |
| Category: Cranial Orthotic | ||||||
| 08/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: VACCINES | ||||||
| 08/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Oncology | ||||||
| 07/11/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Obesity | ||||||
| 05/16/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/02/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/04/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: VACCINE | ||||||
| 02/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Diabetes | ||||||
| 01/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Bone Health | ||||||
| 01/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Inflammation | ||||||
| 08/31/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.91 | General |
| 08/24/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Obesity | ||||||
| 07/27/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2023 | Merck Sharp & Dohme LLC | ROTATEQ (Biological), GARDASIL 9, VAXELIS | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: VACCINE | ||||||
| 05/25/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: NEUROSCIENCE | ||||||
| 04/14/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Cardio-renal | ||||||
| 03/30/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Diabetes | ||||||
| 02/02/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Oncology | ||||||
| 01/06/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 147 | 180 | $28,436 | $6,104 |
| 2022 | 4 | 131 | 160 | $25,484 | $7,326 |
| 2021 | 2 | 37 | 39 | $6,420 | $3,799 |
Total Patients
315
Total Services
379
Medicare Billing
$17,229
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 73 | $11,717 | $2,561 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 43 | $4,755 | $1,517 | 31.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 22 | $4,740 | $1,035 | 21.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 42 | 42 | $7,224 | $990.66 | 13.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 64 | $10,240 | $2,685 | 26.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 41 | 41 | $7,052 | $2,073 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 34 | $3,740 | $1,290 | 34.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 21 | $4,452 | $1,278 | 28.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 15 | 15 | $2,580 | $1,920 | 74.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 24 | $3,840 | $1,878 | 48.9% |
About Dr. Amber Fausneaucht, DO
Dr. Amber Fausneaucht, DO is a Pediatrics healthcare provider based in Kalamazoo, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2017. The National Provider Identifier (NPI) number assigned to this provider is 1235667726.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amber Fausneaucht, DO has received a total of $748.13 in payments from pharmaceutical and medical device companies, with $233.58 received in 2024. These payments were reported across 39 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($748.13).
As a Medicare-enrolled provider, Fausneaucht has provided services to 315 Medicare beneficiaries, totaling 379 services with total Medicare billing of $17,229. Data is available for 3 years (2021–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Kalamazoo, MI
- Active Since 05/26/2017
- Last Updated 09/20/2021
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1235667726
Products in Payments
- VRAYLAR (Drug) $86.59
- UBRELVY (Drug) $85.34
- Ozempic (Drug) $61.99
- QULIPTA (Drug) $46.00
- TRULICITY (Drug) $45.28
- Cologuard Collection Kit (Device) $40.37
- Wegovy (Drug) $38.82
- EVENITY (Biological) $37.00
- ROTATEQ (Biological) $27.70
- FARXIGA (Drug) $26.35
- NURTEC ODT (Drug) $22.78
- TZIELD (Biological) $21.92
- Kerendia (Drug) $20.92
- GARDASIL (Biological) $19.29
- PAXLOVID (Drug) $18.79
- VYVANSE (Drug) $17.70
- Otezla (Drug) $17.52
- TRINTELLIX (Drug) $17.01
- Doc Band (Device) $16.69
- Rybelsus (Drug) $16.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Kalamazoo
Jeannette Gaggino, Md, MD
Pediatrics — Payments: $3,499
Pediatrics $3,499
Dr. Russell Cameron, M.d, M.D
Pediatrics — Payments: $2,317
Pediatrics $2,317
Stephen Mcginnis, Do, DO
Pediatrics — Payments: $1,822
Pediatrics $1,822
Nancy Hilleren, M.d, M.D
Pediatrics — Payments: $1,154
Pediatrics $1,154
Colleen Dodich, Md, MD
Pediatrics — Payments: $1,112
Pediatrics $1,112
Geneva Sagun, Md, MD
Pediatrics — Payments: $953.65
Pediatrics $953.65